DE69813322D1 - Flüssige gonadotropinhaltige Arzneimittel - Google Patents

Flüssige gonadotropinhaltige Arzneimittel

Info

Publication number: DE69813322D1
Authority: DE; Germany
Prior art keywords: liquid medicines; medicines containing; containing gonadotropin; gonadotropin; liquid
Prior art date: 1997-01-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69813322T

Other languages

English (en)

Other versions

DE69813322T2 (de

Inventor

A T P Skrabanja

Den Oetelaar P J M Van

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Akzo Nobel NV

Original Assignee

Akzo Nobel NV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-15

Filing date

1998-01-13

Publication date

2003-05-22

1998-01-13 Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV

2003-05-22 Publication of DE69813322D1 publication Critical patent/DE69813322D1/de

2004-02-19 Application granted granted Critical

2004-02-19 Publication of DE69813322T2 publication Critical patent/DE69813322T2/de

2018-01-14 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

DE69813322T 1997-01-15 1998-01-13 Flüssige gonadotropinhaltige Arzneimittel Expired - Lifetime DE69813322T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP97200099		1997-01-15
EP97200099		1997-01-15

Publications (2)

Publication Number	Publication Date
DE69813322D1 true DE69813322D1 (de)	2003-05-22
DE69813322T2 DE69813322T2 (de)	2004-02-19

Family

ID=8227932

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE122010000011C Pending DE122010000011I1 (de)	1997-01-15	1998-01-13	Flüssige gonadotropinhaltige Arzneimittel
DE69813322T Expired - Lifetime DE69813322T2 (de)	1997-01-15	1998-01-13	Flüssige gonadotropinhaltige Arzneimittel

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DE122010000011C Pending DE122010000011I1 (de)	1997-01-15	1998-01-13	Flüssige gonadotropinhaltige Arzneimittel

Country Status (30)

Country	Link
US (1)	US5929028A (de)
EP (2)	EP0853945B1 (de)
JP (1)	JP4353549B2 (de)
KR (1)	KR100498531B1 (de)
CN (1)	CN1165341C (de)
AR (1)	AR011410A1 (de)
AT (1)	ATE237348T1 (de)
AU (1)	AU736339B2 (de)
BR (1)	BR9800323B1 (de)
CA (1)	CA2226803A1 (de)
CZ (1)	CZ297419B6 (de)
DE (2)	DE122010000011I1 (de)
DK (1)	DK0853945T3 (de)
ES (1)	ES2196474T3 (de)
FR (1)	FR10C0024I2 (de)
HK (1)	HK1010150A1 (de)
HU (1)	HU227154B1 (de)
ID (1)	ID19499A (de)
IL (1)	IL122732A0 (de)
LU (1)	LU91655I2 (de)
MX (1)	MX9800438A (de)
NO (3)	NO322509B1 (de)
NZ (1)	NZ329572A (de)
PL (1)	PL190103B1 (de)
PT (1)	PT853945E (de)
RU (1)	RU2203086C2 (de)
SA (1)	SA98181124B1 (de)
TR (1)	TR199800062A2 (de)
TW (1)	TW518235B (de)
ZA (1)	ZA9883B (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000004913A1 (en) *	1998-07-23	2000-02-03	Eli Lilly And Company	Fsh and fsh variant formulations, products and methods
US20030166525A1 (en)	1998-07-23	2003-09-04	Hoffmann James Arthur	FSH Formulation
JP2007204498A (ja) *	1999-03-01	2007-08-16	Chugai Pharmaceut Co Ltd	長期安定化製剤
JP2000247903A (ja) *	1999-03-01	2000-09-12	Chugai Pharmaceut Co Ltd	長期安定化製剤
CZ200260A3 (cs) *	1999-07-12	2002-04-17	Grandis Biotech Gmbh	Formulace růstového hormonu
BRPI0108553B8 (pt) *	2000-02-22	2021-05-25	Applied Res Systems Ars Holding N V	processo para a purificação de hormônio luteinizante (lh) recombinante humano
US7256184B2 (en) *	2000-10-16	2007-08-14	Rodriguez Victorio C	Treatment of aging disorders in humans
US20030104996A1 (en) *	2001-08-30	2003-06-05	Tiansheng Li	L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
AU2007200662A1 (en) *	2001-08-30	2007-03-08	Kirin-Amgen, Inc.	L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
EP1346843A1 (de) *	2002-03-22	2003-09-24	Fuji Photo Film Co., Ltd.	Bilderzeugungsverfahren
NZ542549A (en)	2003-03-04	2008-11-28	Aspenbio Pharma Inc	Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using single-chain luteinizing hormone
PT1610822E (pt) *	2003-04-02	2011-01-05	Ares Trading Sa	Formulações farmacêuticas líquidas ou liofilizadas de fsh e/ou lh em conjunto com o surfactante não iónico poloxâmero 188 e um agente bacteriostático
US20040248784A1 (en) *	2003-06-03	2004-12-09	Marco Filicori	Unitary combinations of FSH and hCG
JP4871124B2 (ja) *	2003-06-20	2012-02-08	アレストレーディングソシエテアノニム	凍結乾燥ｆｓｈ／ｌｈ製剤
JP4412989B2 (ja) *	2003-12-15	2010-02-10	株式会社日立製作所	複数の記憶システムを有するデータ処理システム
KR100587535B1 (ko) *	2004-02-04	2006-06-08	충남대학교산학협력단	재조합 ｈＦＳＨ 유전자 및 이를 내장하는 발현용 벡터
TWI369401B (en)	2005-07-05	2012-08-01	Ares Trading Sa	Serum-free culture medium for the production of recombinant gonadotropins
KR101105871B1 (ko) *	2005-09-27	2012-01-16	주식회사 엘지생명과학	인 난포자극호르몬의 안정한 용액 제형
US8168206B1 (en)	2005-10-06	2012-05-01	Allergan, Inc.	Animal protein-free pharmaceutical compositions
US8137677B2 (en) *	2005-10-06	2012-03-20	Allergan, Inc.	Non-protein stabilized clostridial toxin pharmaceutical compositions
WO2007056851A1 (en) *	2005-11-17	2007-05-24	Mount Sinai Hospital	Compositions and methods for enhancing ovulation inducing agents
US9249407B2 (en)	2006-02-03	2016-02-02	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
US20150038413A1 (en)	2006-02-03	2015-02-05	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US10221228B2 (en)	2006-02-03	2019-03-05	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US20140113860A1 (en)	2006-02-03	2014-04-24	Prolor Biotech Ltd.	Long-acting polypeptides and methods of producing and administering same
US8946155B2 (en)	2006-02-03	2015-02-03	Opko Biologics Ltd.	Long-acting polypeptides and methods of producing and administering same
US9458444B2 (en)	2006-02-03	2016-10-04	Opko Biologics Ltd.	Long-acting coagulation factors and methods of producing same
US8048849B2 (en)	2006-02-03	2011-11-01	Modigene, Inc.	Long-acting polypeptides and methods of producing same
US8450269B2 (en) *	2006-02-03	2013-05-28	Prolor Biotech Ltd.	Long-acting growth hormone and methods of producing same
US10351615B2 (en)	2006-02-03	2019-07-16	Opko Biologics Ltd.	Methods of treatment with long-acting growth hormone
EP2114004B1 (de) *	2006-09-25	2014-12-17	National University Corporation Tokyo University of Agriculture and Technology	Ultraschall-betriebseinrichtung und mikroröhren-inside-system
KR20080106636A (ko) *	2007-06-04	2008-12-09	동아제약주식회사	사람 융모성 성선자극호르몬 함유 즉시 사용형 주사 용액
CA2692165A1 (en) *	2007-06-25	2008-12-31	Amgen Inc.	Compositions of specific binding agents to hepatocyte growth factor
KR101522217B1 (ko)	2007-06-28	2015-05-21	바이오제너릭스 게엠베하	Ｆｓｈ 제조 세포 클론
SI2219607T1 (sl) *	2007-11-01	2012-09-28	Merck Serono Sa	Tekoäśe formulacije lh
AU2009211331B2 (en) *	2008-02-08	2014-07-03	Theramex HQ UK Limited	Liquid formulation of FSH
TWI488640B (zh)	2008-04-16	2015-06-21	Ferring Int Ct Sa	藥學製劑
CN102309745B (zh) *	2008-09-17	2013-05-08	上海天伟生物制药有限公司	一种卵泡刺激素冻干针剂
CN101347613B (zh) *	2008-09-17	2011-10-26	上海天伟生物制药有限公司	几乎不含亚基的糖蛋白的组合物及其制备方法
CN102202682B (zh) *	2008-11-04	2015-08-19	Aska制药株式会社	含促卵泡激素的水性组合物
US9663778B2 (en)	2009-07-09	2017-05-30	OPKO Biologies Ltd.	Long-acting coagulation factors and methods of producing same
TWI604850B (zh) *	2009-10-05	2017-11-11	菲瑞茵國際中心股份有限公司	藥學製劑
EP2325194A1 (de)	2009-11-24	2011-05-25	Glycotope GmbH	Verfahren zur Reinigung von Glykoproteinen
EP2417982A1 (de) *	2010-07-30	2012-02-15	Ferring B.V.	Stabilisierung von Gonadotropinen
WO2012127501A2 (en) *	2011-03-11	2012-09-27	Sanzyme Limited	Composition for improving endometrial thickness during ovarian stimulation
WO2012127500A2 (en) *	2011-03-11	2012-09-27	Sanzyme Limited	Composition for spermatogenesis
CN103619358B (zh)	2011-03-31	2017-02-15	辉凌公司	药物制剂
US20120265129A1 (en)	2011-04-15	2012-10-18	Neuralight Hd, Llc	Methods for Chronic Pain Management and Treatment using HCG
US8680086B2 (en)	2011-04-15	2014-03-25	Neuralight Hd, Llc	Methods for chronic pain management and treatment using HCG
CA2842323A1 (en)	2011-07-18	2013-01-24	Arts Biologics A/S	Long acting biologically active luteinizing hormone (lh) compound
JO3092B1 (ar)	2011-08-08	2017-03-15	Ferring Bv	مركب لتحفيز مسيطر عليه للمبيض
PE20142405A1 (es)	2012-04-19	2015-01-25	Opko Biolog Ltd	Variantes de oxintomodulina de accion prolongada y metodos de produccion de las mismas
US20150290292A1 (en)	2012-10-18	2015-10-15	Neuralight Hd, Llc	Treatment of Depression and PTSD
US9808534B2 (en)	2012-11-20	2017-11-07	Opko Biologics Ltd.	Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
ES2694328T3 (es)	2013-03-12	2018-12-19	Sumitomo Dainippon Pharma Co., Ltd.	Composición acuosa líquida
WO2014159813A1 (en)	2013-03-13	2014-10-02	Moderna Therapeutics, Inc.	Long-lived polynucleotide molecules
US20150158926A1 (en)	2013-10-21	2015-06-11	Opko Biologics, Ltd.	Long-acting polypeptides and methods of producing and administering same
WO2015075743A1 (en)	2013-11-12	2015-05-28	Cadila Healthcare Limited	Formulation for gonadotropins
LT3209319T (lt) *	2014-10-21	2021-10-25	Hexima Limited	Grybelinių infekcijų gydymo būdas
KR102473014B1 (ko)	2015-06-19	2022-11-30	옵코 바이오로직스 리미티드	장기-작용성 응고 인자 및 그의 제조 방법
GB201603280D0 (en) *	2016-02-24	2016-04-13	Ferring Bv	Stable liquid gonadotropin formulation
SI3436054T2 (sl)	2016-09-13	2022-09-30	Allergan, Inc.	Stabilizirani neproteinski sestavki klostridijskih toksinov
US11110063B2 (en)	2017-08-25	2021-09-07	MAIA Pharmaceuticals, Inc.	Storage stable sincalide formulations
CA3140267A1 (en)	2019-05-16	2020-11-19	Ceva Sante Animale	Compositions and methods for increasing reproduction performance in non-human mammals using recombinant luteinizing hormone
CN112451652A (zh) *	2020-12-07	2021-03-09	苏州智核生物医药科技有限公司	一种重组人促甲状腺素注射液

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4357934A (en) *	1980-07-23	1982-11-09	The Curators Of The University Of Missouri	Method of treating male infertility
US4457916A (en) *	1982-08-31	1984-07-03	Asahi Kasei Kogyo Kabushiki Kaisha	Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
IT1206302B (it) *	1987-06-26	1989-04-14	Serono Cesare Ist Ricerca	Ormone follicolo-stimolante urinario
US5997856A (en) *	1988-10-05	1999-12-07	Chiron Corporation	Method and compositions for solubilization and stabilization of polypeptides, especially proteins
ATE148171T1 (de) *	1989-02-21	1997-02-15	Univ Washington	Modifizierte formen von fortpflanzungshormonen
US5338835A (en) *	1989-02-21	1994-08-16	Washington University	CTP-extended form of FSH
US5114948A (en) *	1989-10-19	1992-05-19	Eli Lilly And Company	Stabilized pergolide compositions
IE64738B1 (en) *	1990-03-20	1995-09-06	Akzo Nv	Stabilized gonadotropin containing preparations
US5384132A (en) *	1990-03-20	1995-01-24	Akzo N.V.	Stabilized gonadotropin containing preparations
US5272135A (en) *	1991-03-01	1993-12-21	Chiron Ophthalmics, Inc.	Method for the stabilization of methionine-containing polypeptides
IT1250075B (it) *	1991-12-18	1995-03-30	Serono Cesare Ist Ricerca	Composizioni farmaceutiche contenenti gonadotropine.
CA2573307C (en) *	1992-04-30	2011-01-04	Millennium Pharmaceuticals, Inc.	Use of platelet aggregation inhibitors
US5281198A (en) *	1992-05-04	1994-01-25	Habley Medical Technology Corporation	Pharmaceutical component-mixing delivery assembly
EP0814841B1 (de) *	1995-03-21	2001-12-05	Applied Research Systems ARS Holding N.V.	Flüssige hcg-formulierungen

1997
- 1997-12-23 IL IL12273297A patent/IL122732A0/xx not_active IP Right Cessation
- 1997-12-23 TW TW086119598A patent/TW518235B/zh not_active IP Right Cessation
1998
- 1998-01-06 ZA ZA9883A patent/ZA9883B/xx unknown
- 1998-01-12 ID IDP980030A patent/ID19499A/id unknown
- 1998-01-13 CN CNB981041493A patent/CN1165341C/zh not_active Expired - Lifetime
- 1998-01-13 ES ES98200068T patent/ES2196474T3/es not_active Expired - Lifetime
- 1998-01-13 NZ NZ329572A patent/NZ329572A/xx not_active IP Right Cessation
- 1998-01-13 EP EP98200068A patent/EP0853945B1/de not_active Expired - Lifetime
- 1998-01-13 PT PT98200068T patent/PT853945E/pt unknown
- 1998-01-13 DE DE122010000011C patent/DE122010000011I1/de active Pending
- 1998-01-13 EP EP02079923A patent/EP1285665A1/de not_active Withdrawn
- 1998-01-13 AT AT98200068T patent/ATE237348T1/de active
- 1998-01-13 DK DK98200068T patent/DK0853945T3/da active
- 1998-01-13 DE DE69813322T patent/DE69813322T2/de not_active Expired - Lifetime
- 1998-01-14 KR KR10-1998-0000785A patent/KR100498531B1/ko not_active IP Right Cessation
- 1998-01-14 CA CA002226803A patent/CA2226803A1/en not_active Abandoned
- 1998-01-14 RU RU98100930/14A patent/RU2203086C2/ru active Protection Beyond IP Right Term
- 1998-01-14 HU HU9800056A patent/HU227154B1/hu active Protection Beyond IP Right Term
- 1998-01-14 AU AU52059/98A patent/AU736339B2/en not_active Expired
- 1998-01-14 AR ARP980100152A patent/AR011410A1/es active IP Right Grant
- 1998-01-14 MX MX9800438A patent/MX9800438A/es active IP Right Grant
- 1998-01-14 PL PL98324279A patent/PL190103B1/pl unknown
- 1998-01-14 JP JP00538998A patent/JP4353549B2/ja not_active Expired - Lifetime
- 1998-01-14 BR BRPI9800323-2A patent/BR9800323B1/pt not_active IP Right Cessation
- 1998-01-14 NO NO19980177A patent/NO322509B1/no not_active IP Right Cessation
- 1998-01-15 TR TR1998/00062A patent/TR199800062A2/xx unknown
- 1998-01-15 CZ CZ0013598A patent/CZ297419B6/cs not_active IP Right Cessation
- 1998-04-14 US US09/006,812 patent/US5929028A/en not_active Expired - Lifetime
- 1998-04-22 SA SA98181124A patent/SA98181124B1/ar unknown
- 1998-10-12 HK HK98111196A patent/HK1010150A1/xx not_active IP Right Cessation
2010
- 2010-02-24 LU LU91655C patent/LU91655I2/fr unknown
- 2010-04-16 FR FR10C0024C patent/FR10C0024I2/fr active Active
- 2010-06-07 NO NO2010013C patent/NO2010013I2/no not_active IP Right Cessation
2021
- 2021-01-12 NO NO2021001C patent/NO2021001I1/no unknown

Also Published As

Publication number	Publication date
LU91655I2 (fr)	2010-04-26
NO980177D0 (no)	1998-01-14
SA98181124B1 (ar)	2006-07-10
HU9800056D0 (en)	1998-03-02
PL324279A1 (en)	1998-07-20
CA2226803A1 (en)	1998-07-15
CZ297419B6 (cs)	2006-12-13
FR10C0024I1 (de)	2010-05-21
NO2010013I1 (no)	2010-06-07
ZA9883B (en)	1998-07-08
JPH10203997A (ja)	1998-08-04
EP1285665A1 (de)	2003-02-26
TR199800062A2 (xx)	1998-08-21
PL190103B1 (pl)	2005-10-31
KR19980070493A (ko)	1998-10-26
NO980177L (no)	1998-07-16
HU227154B1 (en)	2010-08-30
ATE237348T1 (de)	2003-05-15
BR9800323B1 (pt)	2011-04-19
NO2010013I2 (no)	2015-05-18
AU5205998A (en)	1998-07-23
ID19499A (id)	1998-07-16
CN1165341C (zh)	2004-09-08
ES2196474T3 (es)	2003-12-16
FR10C0024I2 (fr)	2011-04-01
NO2021001I1 (no)	2021-01-12
BR9800323A (pt)	1999-06-29
IL122732A0 (en)	1998-08-16
DE122010000011I1 (de)	2010-07-08
RU2203086C2 (ru)	2003-04-27
DK0853945T3 (da)	2003-08-04
DE69813322T2 (de)	2004-02-19
JP4353549B2 (ja)	2009-10-28
NO322509B1 (no)	2006-10-16
US5929028A (en)	1999-07-27
AU736339B2 (en)	2001-07-26
EP0853945A1 (de)	1998-07-22
EP0853945B1 (de)	2003-04-16
KR100498531B1 (ko)	2005-09-30
TW518235B (en)	2003-01-21
NZ329572A (en)	1999-05-28
CN1191139A (zh)	1998-08-26
PT853945E (pt)	2003-08-29
HUP9800056A3 (en)	2001-01-29
HUP9800056A2 (hu)	1998-08-28
AR011410A1 (es)	2000-08-16
HK1010150A1 (en)	1999-06-17
CZ13598A3 (cs)	1998-08-12
MX9800438A (es)	1998-11-30

Legal Events

Date

Code

Title

Description

2017-06-21

R067

Examining division decision granting supplementary protection certificate

Free format text: PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125

Spc suppl protection certif: 122010000011

Filing date: 20100318

Expiry date: 20180114

Extension date: 20230113

2017-07-25

R069

Supplementary protection certificate granted